Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tenaya Therapeutics Inc

0.6096
-0.0819-11.84%
Volume:8.89M
Turnover:5.52M
Market Cap:99.16M
PE:-0.53
High:0.6800
Open:0.6725
Low:0.6096
Close:0.6915
Loading ...

Tenaya Therapeutics Inc. Conducted Annual Stockholders Meeting

Reuters
·
31 May

Tenaya Therapeutics' SVP Finance Tomohiro Higa Reports Disposal of Common Shares

Reuters
·
17 May

Tingley Whittemore, Chief Medical Officer, Reports Disposal of Tenaya Therapeutics Inc. Common Shares

Reuters
·
17 May

CEO Ali Faraz Reports Disposal of Tenaya Therapeutics Inc. Common Shares

Reuters
·
17 May

Tenaya Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
16 May

Analysts’ Top Healthcare Picks: Tenaya Therapeutics (TNYA), Green Thumb Industries (GTBIF)

TIPRANKS
·
12 May

Strong Buy Recommendation for Tenaya Therapeutics Amid Promising Trial Results and Financial Stability

TIPRANKS
·
10 May

Tenaya Therapeutics Reports Q1 2025 Financial Results

TIPRANKS
·
08 May

Buy Rating for Tenaya Therapeutics Driven by Promising Clinical Developments and Strategic Restructuring

TIPRANKS
·
08 May

BRIEF-Tenaya Therapeutics Q1 Net Income USD -26.864 Million

Reuters
·
08 May

Tenaya Therapeutics Inc: Cash Runway Extended Into Second Half of 2026

THOMSON REUTERS
·
08 May

Tenaya Therapeutics Q1 Basic EPS USD -0.24

THOMSON REUTERS
·
08 May

Tenaya Therapeutics Price Target Maintained With a $5.00/Share by HC Wainwright & Co.

Dow Jones
·
25 Apr

Tenaya announces interim data from ongoing RIDGE study

TIPRANKS
·
25 Apr

Promising Clinical Trial Results for TN-201 Support Buy Rating for Tenaya Therapeutics

TIPRANKS
·
31 Mar

Tenaya Therapeutics Announces Late Breaker Presentation of New Data from MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 at American College of Cardiology Annual Meeting

GlobeNewswire
·
31 Mar

BRIEF-Tenaya Therapeutics Inc - On Mar 27, Co Approves Restructuring Plan - SEC Filing

Reuters
·
29 Mar

Tenaya Therapeutics Inc - on Mar 27, Co Approves Restructuring Plan - SEC Filing

THOMSON REUTERS
·
29 Mar

Is Tenaya Therapeutics, Inc. (TNYA) the Cheapest Stock Insiders Are Buying In March?

Insider Monkey
·
28 Mar

Tenaya Therapeutics, Inc. (TNYA): Among Stocks Receiving the Most Insider Love in March

Insider Monkey
·
25 Mar